SpaceX Has Filed Confidentially For IPO, The AI Divide In Venture Capital | Bloomberg Deals 4/1/2026

A weekly midday program features guests from Bain Capital, Axiom Partners, Salesforce Ventures, Westbridge Capital, and Morgan Stanley to discuss high-impact corporate transactions shaping global markets. Coverage signals a focus on M&A activity, private markets and venture investing, and governance themes but contains no actionable market-moving data.

Analysis

The conversation mix — private capital, corporate venture, and traditional M&A advisory — highlights a bifurcating fee pool: recurring private-markets management fees vs. lumpy M&A advisory fees. For banks with scale in wealth and asset management, that bifurcation is an advantage: converting private capital flows into annuitized fees mutes headline volatility from deal cycles and should compress realized revenue volatility over 12–24 months. A sustained 10%+ reacceleration in announced deal value would likely show up in IBD revenue within 6–12 months, but the larger structural prize is capturing allocatable LP capital and co-investment economics where margins can be steadier and higher over time.

Second-order effects matter: more corporate venture and strategic buying reduces the absolute pool of sell-side M&A fees (fewer auctions, more bilateral strategic tuck-ins), and increases demand for integration financing, tax/advisory work and secondary market liquidity — services where full-service banks can cross-sell. That shifts economic benefit from pure advisory boutiques toward firms that combine balance-sheet capabilities, wealth distribution, and private market product sets. Conversely, rapid private capital deployment can depress public M&A activity (less need to buy public competitors), tightening immediate upside for traditional advisory revenue.

Key risks are macro and capital-cost driven — a credit shock or a 100–200bp parallel move up in borrowing costs would choke deal financing and reprice private valuations, reversing the thesis within weeks. Regulatory/conflict scrutiny of banks’ private investments is a second tail risk that could force carve-outs or reduce deal flow over 6–18 months. Near-term catalysts to watch: a cluster of announced strategic acquisitions by large tech corporates, a jump in announced buyout deal value, or quarterly disclosures of growing private-asset AUM that materially change consensus revenue multiple for diversified banks.

Key Decisions for Investors

• Long MS equity (ticker: MS), horizon 6–12 months. Size a core position (3–5% NAV) and buy a 6–9 month 7–10% OTM put to limit downside; target asymmetric return of ~20–30% upside vs 8–12% protected downside if M&A/private-market flows reaccelerate.
• Relative-value pair: Long MS / Short GS, equal-dollar notional, horizon 6–12 months. Rationale: MS benefits more from annuitized private-asset fees and wealth distribution; target relative outperformance of 10–15%. Use a 1:1 hedge and trim if the spread narrows by >50% of initial move.
• Options call-spread on MS to express upside with limited capital: buy 12-month MS 15% OTM calls and sell 12-month MS 35% OTM calls (size to risk tolerance). Expect >2x payoff if M&A announcements and private-asset growth accelerate; max loss = net premium paid.
• Tail hedge / volatility insurance: buy short-dated (3-month) puts on regional/IB-exposed peers or an index of financials to protect against a sudden macro shock that would compress deal activity. Size to cap portfolio drawdown at target (e.g., cost = 0.5–1% NAV) and treat as insurance rather than alpha.